Huntington Lowers FY27 EPS Target to $1.75–$1.83, Raises Buyback to $1.3–$1.4B
HBAN is trading near its 52-week low of $14.89 (13% above the low).
Summary
Huntington lowered its FY27 EPS target to $1.75–$1.83 and trimmed loan, NIM, and fee growth assumptions, while raising expected share repurchases to $1.3–$1.4B.
Key Events · Earnings and Guidance · HBAN
-
FY27 EPS Target Cut
Revised FY27 EPS target range to $1.75–$1.83, down from the prior implied trajectory of $1.52–$1.54 per share.
-
Loan and NIM Assumptions Lowered
FY27 loan growth recalibrated to ~6% (from 7–8%) and net interest margin to low-mid 3.20s (from mid-high 3.20s), reflecting higher deposit costs and weaker loan volumes.
-
Fee Income Growth Slows
FY27 fee income growth revised to high-single digit from low-double digit, with FY26 noninterest income now expected up ~32% YoY.
-
Buyback Increased to $1.3–$1.4B
Expected FY27 share repurchases raised to $1.3–$1.4B, up from roughly $550M completed in FY26, signaling management sees value at current prices.
Analysis · HBAN · Finance
At its Barclays conference presentation, Huntington materially lowered its FY27 earnings outlook while simultaneously increasing its share repurchase plan. The revised FY27 EPS range of $1.75–$1.83 sits below the prior implied $1.52–$1.54 run-rate trajectory, driven by lower loan growth (~6% vs 7–8%), a lower net interest margin (low-mid 3.20s vs mid-high 3.20s), and softer fee income growth. Management cited sustained high short-term rates, elevated deposit pricing competition, and weaker loan volumes — particularly CRE and residential paydowns plus reduced auto production — as the drivers. The offsetting positive is a larger capital return: expected buybacks rise to $1.3–$1.4B for FY27, up from roughly $550M completed in FY26. For a $33.8B market-cap regional bank, the guidance cut is the dominant signal, but the buyback increase shows management still sees value in the stock near $16.77.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 36.7% of the 1072 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.61%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HBAN was trading at $16.77 on NASDAQ in the Finance sector, with a market capitalization of approximately $33.8B. The 52-week trading range was $14.89 to $19.46. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.